FMR LLC 13D and 13G filings for Theravance Biopharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2021-10-12 09:25 am Sale | 2021-10-08 | 13G | Theravance Biopharma, Inc. TBPH | FMR LLC | 2,670,881 3.635% | -6,936,429 (-72.20%) | Filing |
| 2021-02-08 10:33 am Purchase | 2021-02-05 | 13G | Theravance Biopharma, Inc. TBPH | FMR LLC | 9,607,310 15.000% | 1,083,137 (+12.71%) | Filing |